|
126 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3248 News |
|
| 12345678910111213...6566» |
- | colchicine / Generic mfg.
Enrollment change, Trial completion date, Trial termination: Heat Intolerance in the Group of FMF Patients (clinicaltrials.gov) - Apr 4, 2024
P=N/A, N=7, Terminated, Sponsor: Sheba Medical Center
N=15 --> 7 | Trial completion date: Dec 2025 --> Mar 2024 | Enrolling by invitation --> Terminated; unable to recruit patients
- | Enrollment change, Gram positive: Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections (clinicaltrials.gov) - Oct 26, 2023
P=N/A, N=211, Completed, Sponsor: Imperial College London
N=15 --> 7 | Trial completion date: Dec 2025 --> Mar 2024 | Enrolling by invitation --> Terminated; unable to recruit patients N=100 --> 211
- | Trial termination: Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease (clinicaltrials.gov) - May 6, 2023
P=N/A, N=150, Terminated, Sponsor: University of Illinois at Chicago
N=100 --> 211 Completed --> Terminated; PI left institution, not able to contact; data destroyed
- | Enrollment change: TBTech: Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western Kenya (clinicaltrials.gov) - Mar 27, 2023
P=N/A, N=3782, Completed, Sponsor: Indiana University
Completed --> Terminated; PI left institution, not able to contact; data destroyed N=1000 --> 3782
- | vancomycin / Generic mfg.
Trial completion, Enrollment change: Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation (clinicaltrials.gov) - Apr 23, 2019
P2, N=20, Completed, Sponsor: Seoul National University Hospital
N=1000 --> 3782 Recruiting --> Completed | N=86 --> 20
- | Trial completion, Adherence: TXT4MED: Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging (clinicaltrials.gov) - Apr 23, 2019
P=N/A, N=30, Completed, Sponsor: University of Arizona
Recruiting --> Completed | N=86 --> 20 Recruiting --> Completed
- | trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion: Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children (clinicaltrials.gov) - Apr 22, 2019
P3, N=450, Completed, Sponsor: University of Cape Town
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, HEOR, Real-world evidence, Real-world: Effect of Xpert MTB/RIF on Patient Outcomes (clinicaltrials.gov) - Apr 22, 2019
P=N/A, N=776, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date: Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis (clinicaltrials.gov) - Apr 20, 2019
P3, N=331, Completed, Sponsor: Tuberculosis Research Centre, India
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018
- | colchicine / Generic mfg.
Trial completion date, Trial primary completion date: Heat Intolerance in the Group of FMF Patients (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=15, Enrolling by invitation, Sponsor: Sheba Medical Center
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jun 2018 Trial completion date: Dec 2018 --> Dec 2025 | Trial primary completion date: Aug 2018 --> Aug 2025
- | Trial completion, Gram negative: Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=604, Completed, Sponsor: Rabin Medical Center
Trial completion date: Dec 2018 --> Dec 2025 | Trial primary completion date: Aug 2018 --> Aug 2025 Recruiting --> Completed
- | Trial completion: Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=330, Completed, Sponsor: University of British Columbia
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: TANDEM: Pulmonary Tuberculosis Patients With Diabetes Mellitus (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=350, Completed, Sponsor: Universitas Padjadjaran
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: The Diagnostic Validity of the Urea Breath Test (clinicaltrials.gov) - Apr 18, 2019
P=N/A, N=1200, Completed, Sponsor: Seoul National University Bundang Hospital
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2022 --> Dec 2018 | Trial primary completion date: Dec 2022 --> Dec 2018
- | Trial completion: Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB (clinicaltrials.gov) - Apr 17, 2019
P=N/A, N=200, Completed, Sponsor: Chinese University of Hong Kong
Recruiting --> Completed | Trial completion date: Dec 2022 --> Dec 2018 | Trial primary completion date: Dec 2022 --> Dec 2018 Recruiting --> Completed
- | Trial completion, Trial completion date: MRI Differentiating Gut TB and Crohn's (clinicaltrials.gov) - Apr 17, 2019
P=N/A, N=120, Completed, Sponsor: The University of Hong Kong
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019
- | Trial completion date, Trial primary completion date: The Diagnostic Validity of the Urea Breath Test (clinicaltrials.gov) - Apr 16, 2019
P=N/A, N=1200, Recruiting, Sponsor: Seoul National University Bundang Hospital
Recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019 Trial completion date: Jan 2018 --> Dec 2022 | Trial primary completion date: Jan 2018 --> Dec 2022
- | Shanchol (oral cholera vaccine) / Sanofi
Trial termination: Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi (clinicaltrials.gov) - Apr 16, 2019
P=N/A, N=2758, Terminated, Sponsor: Johns Hopkins Bloomberg School of Public Health
Trial completion date: Jan 2018 --> Dec 2022 | Trial primary completion date: Jan 2018 --> Dec 2022 Completed --> Terminated; Financial reason
- | Trial completion, Enrollment change, Trial completion date: INCREMENT-SOT: Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (clinicaltrials.gov) - Mar 28, 2019
P=N/A, N=820, Completed, Sponsor: Spanish Network for Research in Infectious Diseases
Completed --> Terminated; Financial reason Active, not recruiting --> Completed | N=400 --> 820 | Trial completion date: Dec 2018 --> Jan 2018
- | pretomanid (PA-824) / Global Alliance for TB Drug Development
Enrollment change: STAND: Shortening Treatment by Advancing Novel Drugs (clinicaltrials.gov) - Mar 26, 2019
P3, N=284, Completed, Sponsor: Global Alliance for TB Drug Development
Active, not recruiting --> Completed | N=400 --> 820 | Trial completion date: Dec 2018 --> Jan 2018 N=1500 --> 284
- | Trial completion, Trial completion date, Trial primary completion date: Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection (clinicaltrials.gov) - Mar 26, 2019
P4, N=589, Completed, Sponsor: National Taiwan University Hospital
N=1500 --> 284 Recruiting --> Completed | Trial completion date: Nov 2018 --> May 2018 | Trial primary completion date: Aug 2018 --> Mar 2018
- | Trial completion: Helipro: Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori (clinicaltrials.gov) - Mar 26, 2019
P=N/A, N=100, Completed, Sponsor: Algemeen Ziekenhuis Maria Middelares
Recruiting --> Completed | Trial completion date: Nov 2018 --> May 2018 | Trial primary completion date: Aug 2018 --> Mar 2018 Recruiting --> Completed
- | Trial completion: Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis (clinicaltrials.gov) - Mar 20, 2019
P=N/A, N=20, Completed, Sponsor: Lille Catholic University
Recruiting --> Completed Active, not recruiting --> Completed
- | Biomarker, Trial completion: Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=270, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed Recruiting --> Completed
- | levofloxacin / Generic mfg., tetracycline / Generic mfg., esomeprazole / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Comparison of Two Rescue Therapies for Helicobacter Pylori Infection (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=51, Completed, Sponsor: Kaohsiung Veterans General Hospital.
Recruiting --> Completed Recruiting --> Completed | N=160 --> 51 | Trial completion date: Nov 2016 --> Oct 2017 | Trial primary completion date: Nov 2016 --> Jul 2017
- | levofloxacin / Generic mfg., tetracycline / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=102, Completed, Sponsor: Kaohsiung Veterans General Hospital.
Recruiting --> Completed | N=160 --> 51 | Trial completion date: Nov 2016 --> Oct 2017 | Trial primary completion date: Nov 2016 --> Jul 2017 Recruiting --> Completed | Trial completion date: Jun 2017 --> Sep 2017 | Trial primary completion date: Feb 2017 --> Sep 2017
- | Trial completion, Enrollment change, Trial completion date: TasP in Correctional Facilities (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=419, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed | Trial completion date: Jun 2017 --> Sep 2017 | Trial primary completion date: Feb 2017 --> Sep 2017 N=6000 --> 419 | Trial completion date: Dec 2018 --> Mar 2018 | Recruiting --> Completed
- | chlorhexidine gluconate / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery (clinicaltrials.gov) - Mar 11, 2019
P4, N=100, Completed, Sponsor: Metro Health, Michigan
N=6000 --> 419 | Trial completion date: Dec 2018 --> Mar 2018 | Recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2019 --> Dec 2017 | Trial primary completion date: Oct 2019 --> Dec 2017
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Screening of Gonococcal and Chlamydial Infections in the Third Trimester (clinicaltrials.gov) - Feb 21, 2019
P=N/A, N=1691, Completed, Sponsor: St. Michael's Hospital, Toronto
Recruiting --> Completed | Trial completion date: Dec 2019 --> Dec 2017 | Trial primary completion date: Oct 2019 --> Dec 2017 Enrolling by invitation --> Completed | N=1000 --> 1691 | Trial completion date: Nov 2018 --> Feb 2019 | Trial primary completion date: Nov 2018 --> Feb 2019
- | Trial completion, Trial completion date, Trial primary completion date: Safer Sex Program for Young African-American Men (clinicaltrials.gov) - Feb 21, 2019
P2, N=620, Completed, Sponsor: Richard Crosby
Enrolling by invitation --> Completed | N=1000 --> 1691 | Trial completion date: Nov 2018 --> Feb 2019 | Trial primary completion date: Nov 2018 --> Feb 2019 Recruiting --> Completed | Trial completion date: May 2019 --> Apr 2018 | Trial primary completion date: May 2018 --> Nov 2017
- ||||||| vancomycin / Generic mfg.
Trial completion, Enrollment change: Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis (clinicaltrials.gov) - Feb 16, 2019
P3, N=303, Completed, Sponsor: Kurobe LLC
Recruiting --> Completed | Trial completion date: May 2019 --> Apr 2018 | Trial primary completion date: May 2018 --> Nov 2017 Recruiting --> Completed | N=150 --> 303
- ||| Trial completion, Enrollment change: Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects (clinicaltrials.gov) - Feb 7, 2019
P=N/A, N=13, Completed, Sponsor: DiaSorin Inc.
Recruiting --> Completed | N=150 --> 303 Recruiting --> Completed | N=20 --> 13
- | Trial completion, Enrollment change: Rheumatic Heart Disease Prevalence in Leon, Nicaragua (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=2193, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed | N=20 --> 13 Recruiting --> Completed | N=3600 --> 2193
- | Trial completion: LINEZOLIDE: Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=31, Completed, Sponsor: Groupe Hospitalier Paris Saint Joseph
Recruiting --> Completed | N=3600 --> 2193 Active, not recruiting --> Completed
- | Trial completion: A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding (clinicaltrials.gov) - Jan 31, 2019
P=N/A, N=200000, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: Immunity to Human Cholera in Bangladesh (clinicaltrials.gov) - Jan 31, 2019
P=N/A, N=400, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults (clinicaltrials.gov) - Jan 25, 2019
P=N/A, N=115, Completed, Sponsor: Sheba Medical Center
Recruiting --> Completed Recruiting --> Completed | N=200 --> 115 | Trial completion date: Jun 2019 --> Nov 2018 | Trial primary completion date: Dec 2018 --> Aug 2018
- | Trial completion: CARESS_PREMI: Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants (clinicaltrials.gov) - Jan 24, 2019
P=N/A, N=525, Completed, Sponsor: Rennes University Hospital
Recruiting --> Completed | N=200 --> 115 | Trial completion date: Jun 2019 --> Nov 2018 | Trial primary completion date: Dec 2018 --> Aug 2018 Recruiting --> Completed
- | Trial completion: CATS-CARE: Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=20, Completed, Sponsor: Laura Fanucchi
Recruiting --> Completed Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: PCT-MI: Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=116, Completed, Sponsor: Centre Hospitalier Universitaire, Amiens
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Aug 2018 --> Oct 2016 | Trial primary completion date: Aug 2018 --> Oct 2016
- | Trial completion: Causes of Fever in Bangladeshi Patients (clinicaltrials.gov) - Jan 19, 2019
P=N/A, N=416, Completed, Sponsor: University of Oxford
Recruiting --> Completed | Trial completion date: Aug 2018 --> Oct 2016 | Trial primary completion date: Aug 2018 --> Oct 2016 Recruiting --> Completed
- | ceftriaxone / Generic mfg., doxycycline / Generic mfg.
Enrollment change, Trial completion date, Trial primary completion date: Study of Lyme Neuroborreliosis (clinicaltrials.gov) - Jan 16, 2019
P4, N=210, Completed, Sponsor: Turku University Hospital
Recruiting --> Completed N=150 --> 210 | Trial completion date: May 2016 --> Dec 2018 | Trial primary completion date: May 2016 --> Dec 2017
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date, Adherence: Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism (clinicaltrials.gov) - Jan 14, 2019
P=N/A, N=137, Completed, Sponsor: Centre Hospitalier Universitaire de Nīmes
N=150 --> 210 | Trial completion date: May 2016 --> Dec 2018 | Trial primary completion date: May 2016 --> Dec 2017 Recruiting --> Completed | N=100 --> 137 | Trial completion date: Mar 2018 --> May 2018 | Trial primary completion date: Mar 2018 --> May 2018
- || Vabomere (meropenem/vaborbactam) / Melinta Therap
Enrollment change, Trial initiation date, Trial withdrawal: TANGOIII: A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (clinicaltrials.gov) - Jan 11, 2019
P3, N=0, Withdrawn, Sponsor: Melinta Therapeutics, Inc.
Recruiting --> Completed | N=100 --> 137 | Trial completion date: Mar 2018 --> May 2018 | Trial primary completion date: Mar 2018 --> May 2018 N=790 --> 0 | Initiation date: Feb 2017 --> Aug 2018 | Not yet recruiting --> Withdrawn
- | Enrollment change, Trial withdrawal: Safety and Immunogenicity Study of GX-70 in TB Patient (clinicaltrials.gov) - Jan 11, 2019
P1, N=0, Withdrawn, Sponsor: Yonsei University
N=790 --> 0 | Initiation date: Feb 2017 --> Aug 2018 | Not yet recruiting --> Withdrawn N=18 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion, Enrollment change, Trial completion date: Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women (clinicaltrials.gov) - Jan 7, 2019
P=N/A, N=42, Completed, Sponsor: University of Alabama at Birmingham
N=18 --> 0 | Not yet recruiting --> Withdrawn Enrolling by invitation --> Completed | N=200 --> 42 | Trial completion date: May 2019 --> Jan 2019
- | Isentress (raltegravir) / Merck (MSD)
Trial completion, Trial completion date, Combination therapy, Head-to-Head: REFLATE TB2: Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (clinicaltrials.gov) - Dec 31, 2018
P3, N=460, Completed, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Enrolling by invitation --> Completed | N=200 --> 42 | Trial completion date: May 2019 --> Jan 2019 Active, not recruiting --> Completed | Trial completion date: Sep 2019 --> Nov 2018
- | Trial completion, Trial completion date, Surgery: ORAL-ISO: Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer (clinicaltrials.gov) - Dec 21, 2018
P3, N=80, Completed, Sponsor: Rennes University Hospital
Active, not recruiting --> Completed | Trial completion date: Sep 2019 --> Nov 2018 Recruiting --> Completed | Trial completion date: Feb 2019 --> Sep 2018
- | Trial termination: CAMERA2: Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection (clinicaltrials.gov) - Dec 20, 2018
P3, N=358, Terminated, Sponsor: Menzies School of Health Research
Recruiting --> Completed | Trial completion date: Feb 2019 --> Sep 2018 Active, not recruiting --> Terminated; Recommendation of the Data Safety Monitoring Committee
- | etonogestrel/ethinylestradiol intravaginal ring / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity (clinicaltrials.gov) - Dec 10, 2018
P4, N=120, Completed, Sponsor: University of Washington
Active, not recruiting --> Terminated; Recommendation of the Data Safety Monitoring Committee Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Nov 2018